Find Barasertib manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

API Suppliers

API Suppliers

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Azd1152, 722543-31-9, Azd-1152, Barasertib [inn], Azd 1152, 957881-03-7
Molecular Formula
C26H31FN7O6P
Molecular Weight
587.5  g/mol
InChI Key
GBJVVSCPOBPEIT-UHFFFAOYSA-N
FDA UNII
16XC2U7W8N

Barasertib
Barasertib is an orally bioavailable, small-molecule, dihydrogen phosphate prodrug of the pyrazoloquinazoline Aurora kinase inhibitor AZD1152-hydroxyquinazoline pyrazol anilide (AZD1152-HQPA) with potential antineoplastic activity. Upon administration and rapid conversion from the prodrug form in plasma, AZD1152-HQPA specifically binds to and inhibits Aurora kinase B, which results in the disruption of spindle checkpoint functions and chromosome alignment and, so, the disruption of chromosome segregation and cytokinesis. Consequently, cell division and cell proliferation are inhibited and apoptosis is induced in Aurora kinase B-overexpressing tumor cells. Aurora kinase B, a serine/threonine protein kinase that functions in the attachment of the mitotic spindle to the centromere, is overexpressed in a wide variety of cancer cell types.
1 2D Structure

Barasertib

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
2-[ethyl-[3-[4-[[5-[2-(3-fluoroanilino)-2-oxoethyl]-1H-pyrazol-3-yl]amino]quinazolin-7-yl]oxypropyl]amino]ethyl dihydrogen phosphate
2.1.2 InChI
InChI=1S/C26H31FN7O6P/c1-2-34(10-12-40-41(36,37)38)9-4-11-39-21-7-8-22-23(16-21)28-17-29-26(22)31-24-14-20(32-33-24)15-25(35)30-19-6-3-5-18(27)13-19/h3,5-8,13-14,16-17H,2,4,9-12,15H2,1H3,(H,30,35)(H2,36,37,38)(H2,28,29,31,32,33)
2.1.3 InChI Key
GBJVVSCPOBPEIT-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CCN(CCCOC1=CC2=C(C=C1)C(=NC=N2)NC3=NNC(=C3)CC(=O)NC4=CC(=CC=C4)F)CCOP(=O)(O)O
2.2 Other Identifiers
2.2.1 UNII
16XC2U7W8N
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 2-((3-((4-((5-(2-((3-fluorophenyl)amino)-2-oxoethyl)-1h-pyrazol-3-yl)amino)quinazolin-7-yl)oxy)propyl)(ethyl)amino)ethyl Dihydrogen Phosphate

2. Azd 1152

3. Azd-1152

4. Azd1152

2.3.2 Depositor-Supplied Synonyms

1. Azd1152

2. 722543-31-9

3. Azd-1152

4. Barasertib [inn]

5. Azd 1152

6. 957881-03-7

7. Barasertib (who-dd)

8. 2-(ethyl(3-((4-((5-(2-((3-fluorophenyl)amino)-2-oxoethyl)-1h-pyrazol-3-yl)amino)quinazolin-7-yl)oxy)propyl)amino)ethyl Dihydrogen Phosphate

9. 16xc2u7w8n

10. Chembl415049

11. Barasertib [who-dd]

12. 2-(ethyl(3-(4-(5-(2-(3-fluorophenylamino)-2-oxoethyl)-1h-pyrazol-3-ylamino)quinazolin-7-yloxy)propyl)amino)ethyl Dihydrogen Phosphate

13. 5-[[7-[3-[ethyl[2-(phosphonooxy)ethyl]amino]propoxy]-4-quinazolinyl]amino]-n-(3-fluorophenyl)-1h-pyrazole-3-acetamide

14. 2-(ethyl(3-((4-((3-(2-((3-fluorophenyl)amino)-2-oxoethyl)-1h-pyrazol-5-yl)amino)quinazolin-7-yl)oxy)propyl)amino)ethyl Dihydrogen Phosphate

15. 2-[ethyl-[3-[4-[[5-[2-(3-fluoroanilino)-2-oxoethyl]-1h-pyrazol-3-yl]amino]quinazolin-7-yl]oxypropyl]amino]ethyl Dihydrogen Phosphate

16. Azd1152 (barasertib)

17. Barasertibum

18. Unii-16xc2u7w8n

19. 2-{ethyl[3-({4-[(5-(2-[(3-fluorophenyl)amino]-2-oxoethyl}-1h-pyrazol-3-yl)amino]quinazolin-7-yl}oxy)propyl]amino}ethyl Dihydrogen Phosphate

20. Kinome_3324

21. 2-naphthylacrylate

22. Schembl613582

23. Gtpl7332

24. Schembl16671950

25. Dtxsid00222583

26. Chebi:167636

27. Bcpp000362

28. Hms3674c21

29. Hms3747e05

30. Bcp01734

31. Bcp13793

32. Cs-d0326

33. Ex-a3656

34. Azd1152-hqpa Dihydrogen Phosphate

35. Bdbm50241089

36. Nsc799355

37. Zinc43129461

38. Bcp9000360

39. Cs-0978

40. Cs-w000582

41. Db11747

42. Nsc-799355

43. Sb16659

44. Azd1152, 33

45. Ncgc00378734-03

46. Ac-35703

47. As-17018

48. Hy-10127

49. Db-074538

50. A9414

51. Ft-0662378

52. Ft-0736007

53. A15011

54. 543e319

55. 881a037

56. Q27074865

57. 1h-pyrazole-3-acetamide, 5-((7-(3-(ethyl(2- (phosphonooxy)ethyl)amino)propoxy)-4-quinazolinyl)amino)-n-(3-fluorophenyl)-

58. 1h-pyrazole-3-acetamide, 5-((7-(3-(ethyl(2-(phosphonooxy)ethyl)amino)propoxy)-4-quinazolinyl)amino)-n-(3-fluorophenyl)-

59. 1h-pyrazole-3-acetamide,5-[[7-[3-[ethyl[2-(phosphonooxy)ethyl]amino]propoxy]-4-quinazolinyl]amino]-n-(3-fluorophenyl)-

60. 2-[ethyl(3-{[4-({5-[2-(3-fluoroanilino)-2-oxoethyl]-1h-pyrazol-3-yl}amino)quinazolin-7-yl]oxy}propyl)amino]ethyl Dihydrogen Phosphate

61. 2-ethyl3-4-5-2-3-fluorophenylamino)-2-oxoethyl)-1h-pyrazol-3-ylamino)quinazolin-7-yloxy)propyl)amino)ethyl Dihydrogen Phosphate

62. N-(3-fluorophenyl)-3-[[7-[3-[ethyl[2-(phosphonooxy)ethyl]amino]propyloxy]quinazoline-4-yl]amino]-1h-pyrazole-5-acetamide

2.4 Create Date
2006-10-26
3 Chemical and Physical Properties
Molecular Weight 587.5 g/mol
Molecular Formula C26H31FN7O6P
XLogP3-0.4
Hydrogen Bond Donor Count5
Hydrogen Bond Acceptor Count12
Rotatable Bond Count15
Exact Mass587.20574689 g/mol
Monoisotopic Mass587.20574689 g/mol
Topological Polar Surface Area175 Ų
Heavy Atom Count41
Formal Charge0
Complexity859
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty